$7.05 -0.01 (-0.14%)
11/6/2009 4:00 PM

Orexigen Therapeutics, Inc. (OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Current Price $7.05 Mkt Cap $327.36M
Open $7.00 P/E Ratio 5.91
Prev. Close $7.06 Div. (Yield) N/A (N/A)
Daily Range $6.86 - $7.16 Volume 520,405
52-Wk Range $1.55 - $10.83 Avg. Daily Vol. 755,000

OREX News and Commentary

Caps

How do you think OREX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

92 Outperform
32 Underperform
 

All-Star Members

41 Outperform
15 Underperform
 

Wall Street

7 Outperform
1 Underperform
 

Top OREX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

fiordwalker (< 20)
Submitted March 25, 2008

weight loss drug could be a blockbuster

albanyfx (39.23)
Submitted February 29, 2008

OREX management panicked and accepted any horrible deal to get their hands on some cash. But there are a whole host of medical, technology, finance, manufacturing and retail names out there that are starving for capital. And you better believe that… More

OREX VS S&P 500 (SPY)

Fools bullish on OREX are also bullish on:

Fools bearish on OREX are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about OREX.

Recs

0
Member Avatar Doris411 (< 20) Submitted: 10/24/2009 5:34:48 PM : Outperform Start Price: $8.01 OREX Score: -11.00

They're finally going to get a drug onto the market in 2010

Recs

0
Member Avatar TMFmrquakeroats (86.73) Submitted: 9/8/2009 9:59:28 AM : Underperform Start Price: $8.25 OREX Score: +21.25

Rated one star.

Recs

0
Member Avatar bklynmp3j (96.96) Submitted: 8/25/2009 12:34:34 AM : Outperform Start Price: $8.24 OREX Score: -18.57

insider buying

Leaderboard

Find the members with the highest scoring picks in OREX.

Score Leader

bigsmitty52

bigsmitty52 (98.66) Score: +145.27

You can't go wrong betting on Americans getting fatter.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
pdt24 < 20 3/30/2009 Outperform 5Y $2.80 +151.79% +36.48% +115.31
manetheren86 93.78 5/18/2009 Outperform 5Y $3.03 +132.67% +19.74% +112.93
Renton405 88.64 5/12/2009 Outperform 5Y $3.09 +128.16% +18.14% +110.02
gerbs87 97.73 5/12/2009 Outperform NS $3.09 +128.16% +18.14% +110.02
cschier < 20 5/15/2009 Outperform 5Y $3.09 +128.16% +21.13% +107.03
portefeuille 99.97 5/27/2009 11/6/2009 Outperform 5Y $3.14 +124.52% +18.39% +106.14
CRAZYCAPTAIN 99.30 5/4/2009 Outperform 1Y $3.10 +127.42% +22.25% +105.17
ProCreditXpress 99.56 5/26/2009 Outperform NS $3.10 +127.42% +22.50% +104.92
5DollarFool 98.30 5/26/2009 Outperform NS $3.10 +127.42% +22.50% +104.92
CaptainFiveBaggr 99.82 6/10/2009 Outperform 5Y $3.93 +79.39% +13.38% +66.01

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer < 20 10/2/2009 Underperform 3W $9.04 -22.01% +4.53% +26.54
TrackRodmanRen < 20 6/24/2009 Outperform NS $4.73 +49.05% +18.43% +30.62
TrackLeerinkSwan 84.26 8/25/2008 Outperform NS $11.51 -38.75% -14.18% -24.57
TrackCowenandCo 74.62 4/3/2008 Outperform NS $10.56 -33.24% -18.31% -14.93
TrackLazardCapit < 20 2/6/2008 Outperform NS $11.67 -39.59% -16.98% -22.61
TrackCanaccord 84.17 2/4/2008 Outperform NS $11.59 -39.17% -19.49% -19.68
TrackJPMorgan 78.71 6/7/2007 Outperform NS $17.76 -60.30% -25.27% -35.03
TrackJMP < 20 6/6/2007 Outperform NS $18.35 -61.58% -25.93% -35.65

Featured Broker Partners